GlassScriptPhysician profile
Craig A Frayer
NPI 1093799777
$726.55
in general payments reported to CMS, 2019-2025
9 companies · $111 in 2025
The $111 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $50.55 · 2020: $62.91 · 2021: $230 · 2022: $61.50 · 2023: $97.03 · 2024: $113 · 2025: $111.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $321.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $321.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $175.83 | 2021-2025 | Nexplanon |
| Abbvie INC. | $157.89 | 2019-2021 | |
| Exeltis, USA INC. | $134.77 | 2020-2024 | Slynd |
| Astellas Pharma US INC | $103.83 | 2023-2025 | Veozah |
| Medtronic, INC. | $52.29 | 2021-2025 | Inceptiv |
| Bayer Healthcare Pharmaceuticals INC. | $32.40 | 2020-2021 | |
| Merck Sharp & Dohme LLC | $28.31 | 2020-2021 | |
| Optumhealth Care Solutions, LLC | $21.85 | 2025 | Vivify Health Care Team Portal 001, Eitan Medical |
| Medicem INC. | $19.38 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Craig Frayer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.